Australian genomic life science company EZZ Life Science (ASX: EZZ) has won approval from the United States (US) Food and Drug Administration (FDA) for nine of its products in the food category, presenting a significant US expansion opportunity for EZZ. | ASX announcement: https://announcements.asx.com.au/asxpdf/20240625/pdf/064x2fh3lh72px.pdf
LSR
0.011
83.3%
IS3
0.001
-75%
ADY
0.006
50%
ADR
0.004
-33.3%
C7A
0.003
50%
TEG
0.002
-33.3%
AON
0.007
40%
L1M
0.043
-28.3%
GTE
0.011
37.5%
ZMM
0.008
-27.3%
MEG
0.023
35.3%
FIN
0.003
-25%
ALM
0.004
33.3%
MKL
0.015
-25%
FCT
0.016
33.3%
RGL
0.003
-25%
FHS
0.004
33.3%
TYX
0.003
-25%
GLH
0.068
33.3%
VRC
0.003
-25%
GTR
0.004
33.3%
WBE
0.003
-25%
GBZ
0.017
30.8%
GLA
0.007
-22.2%
VR1
0.037
27.6%
NHE
0.019
-20.8%
MTM
0.715
25.4%
ADG
0.004
-20%
AAU
0.005
25%
MEM
0.004
-20%
CTN
0.005
25%
SKK
0.004
-20%
SIS
0.005
25%
VEN
0.004
-20%
THR
0.011
22.2%
SRL
0.805
-18.7%
KNB
0.039
21.9%
HIQ
0.014
-17.6%
RPG
0.063
21.2%
EM2
0.005
-16.7%
